Indaptus Therapeutics Enters Stock Purchase Agreement for $12 Million

Indaptus Therapeutics entered into a definitive agreement to sell up to 20 million common shares at $0.60 per share, generating approximately $12 million. This private placement will bolster the company's liquidity under existing securities exemptions.